-+ 0.00%
-+ 0.00%
-+ 0.00%

Sana Biotechnology Achieves Potent In Vivo Gene Editing of Human Stem Cells Using Fusogen Technology

Reuters·12/08/2025 14:00:16

Please log in to view news